Seeking Alpha

Quest Diagnostics (DGX +4.3%) surges, thanks to a 1996 deal with Merck over osteoporosis drug...

Quest Diagnostics (DGX +4.3%) surges, thanks to a 1996 deal with Merck over osteoporosis drug odanacatib, which may pay off to the tune of $75M. (earlier: success of odanacatib)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|